Amcor plc (AMCR) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call presents mixed signals: positive EBIT growth, margin improvements, and synergies suggest strong financial health. However, challenges like volume declines, particularly in Europe, and lack of clarity on divestment timelines pose concerns. The Q&A reveals management's cautious approach and uncertainties in certain sectors. Despite strong EPS growth projections, flat volume expectations and market softness in key areas temper optimism. Without a market cap, the impact on stock price is uncertain, leading to a neutral prediction.
Key Financial Performance
Adjusted EPS $0.193 per share, increasing 18% year-over-year. This includes the addition of the Berry business and was supported by disciplined cost-out performance, improved productivity, and synergy delivery.
Total Recordable Incident Rate 0.55, a slight increase compared to last year, attributed to the acquisition of a business.
Synergies Delivered $38 million during the quarter, towards the upper end of the guidance range. This includes $33 million benefiting EBIT and $5 million related to interest.
Net Sales (Global Flexible Packaging Solutions) Increased 25% on a constant currency basis due to the Berry acquisition. On a comparable basis, net sales were down 2% due to a 2.8% decline in volumes.
Adjusted EBIT (Global Flexible Packaging Solutions) $426 million, up 28% on a constant currency basis, driven by $75 million in acquired earnings and synergy benefits. On a comparable basis, EBIT was up 2%.
EBIT Margin (Global Flexible Packaging Solutions) 13.1%, up 20 basis points year-over-year.
Net Sales (Global Rigid Packaging Solutions) Increased 205% on a constant currency basis due to the Berry acquisition. On a comparable basis, net sales were lower due to a 1% volume decline and unfavorable price/mix.
Adjusted EBIT (Global Rigid Packaging Solutions) $295 million, up 365% on a constant currency basis, driven by $240 million in acquired earnings and synergy benefits. On a comparable basis, EBIT was up 3%.
EBIT Margin (Global Rigid Packaging Solutions) 11.9%, up 420 basis points year-over-year.
Free Cash Outflow $343 million, an improvement of more than $160 million year-over-year before acquisition-related costs.
CapEx $238 million, up from last year due to the Berry acquisition.
Leverage 3.6x, in line with expectations, with a target of 3.1x to 3.2x by fiscal year-end.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Expanded Offerings and Innovation Capabilities: Amcor is now operating as a combined company with Berry, enhancing its offerings and innovation capabilities in consumer packaging and dispensing solutions for Nutrition, Health Care, and Beauty and Wellness.
Revenue Synergies: Secured more than $70 million in annualized sales revenue from new business wins, with a strong pipeline building.
Geographic Expansion: Leveraging Berry's solutions into Amcor's Latin America and Asia Pacific footprint.
Emerging Markets Growth: Emerging markets, particularly Asia, performed better than developed markets.
Synergy Realization: Delivered $38 million in synergies in Q1, with a target of $260 million for fiscal '26 and $650 million by fiscal '28.
Cost and Productivity Improvements: Disciplined cost performance and improved productivity contributed to margin expansion and earnings growth.
Portfolio Optimization: Entered agreements to sell two noncore businesses for $100 million, with further actions anticipated.
Core Portfolio Focus: Defined core portfolio in Nutrition, Health Care, and Beauty and Wellness, with plans to divest noncore assets.
Strategic Growth Initiatives: Focused on cross-selling opportunities, combined solution offerings, and targeting six key focus categories for long-term growth.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Safety Performance: Slight increase in total recordable incident rate to 0.55 compared to last year, attributed to the acquisition of a new business. Opportunities for improvement have been identified, but this poses a risk to operational safety.
Noncore Asset Management: The company is addressing noncore assets and has entered agreements to sell two businesses for $100 million. However, the divestment of noncore assets could pose challenges in maintaining focus and operational efficiency during the transition.
Volume Decline: Overall volumes were down approximately 2% in the quarter, with developed markets like North America and Europe experiencing low single-digit declines. This could impact revenue and profitability.
Emerging Market Performance: While emerging markets like Asia showed growth, Latin America experienced lower demand, which could hinder overall market expansion efforts.
Macroeconomic Environment: The company’s guidance does not rely on improvements in the macroeconomic environment or consumer demand, which could be a risk if economic conditions worsen.
Integration of Berry Acquisition: While integration is progressing well, the process involves significant complexity, including achieving $650 million in synergies by fiscal 2028. Failure to meet these targets could impact financial performance.
Supply Chain Risk: The company highlighted its ability to mitigate supply chain risks, but any disruptions could still impact operations and customer satisfaction.
Leverage and Debt Management: Leverage exiting the quarter was 3.6x, with plans to reduce it to 3.1x-3.2x by fiscal year-end. High leverage could pose financial risks if cash flow targets are not met.
Capital Expenditure: CapEx increased to $238 million, with expectations of $850-$900 million for fiscal 2026. This high level of investment could strain financial resources if returns are not realized as planned.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Synergy Realization: Amcor is on track to deliver $260 million in synergy benefits in fiscal 2026 and $650 million through fiscal 2028. This includes $38 million in synergies achieved in Q1 2026, with $33 million benefiting EBIT and $5 million related to interest.
Portfolio Optimization: Amcor is addressing noncore assets, with agreements to sell two businesses for $100 million. Additional actions on noncore assets are anticipated this fiscal year.
Revenue Synergies: Amcor has secured $70 million in annualized sales from new business wins and is building a strong pipeline of revenue synergies. Examples include cross-selling opportunities and combined solution offerings.
Core Portfolio Focus: Amcor is focusing on Nutrition, Health Care, and Beauty and Wellness markets, which are large, stable, and have attractive margin profiles. The company is exploring strategic alternatives for businesses less aligned with this core portfolio.
Strategic Growth Initiatives: Amcor is leveraging the Berry acquisition to expand geographic reach, cross-sell products, and provide combined solutions. The company is targeting low single-digit volume growth in its core portfolio, translating to long-term earnings growth.
Earnings Per Share (EPS) Growth: Amcor reaffirms fiscal 2026 EPS guidance of $0.80 to $0.83 per share, representing 12% to 17% growth. This growth is supported by synergy realization and is not dependent on macroeconomic improvements.
Free Cash Flow: Amcor expects free cash flow of $1.8 billion to $1.9 billion in fiscal 2026, doubling fiscal 2025 cash flow. This includes $220 million in integration and transaction costs.
Capital Expenditures: Capital spending is expected to range between $850 million and $900 million in fiscal 2026, with depreciation slightly exceeding CapEx.
Leverage and Balance Sheet: Amcor aims to reduce leverage to 3.1x to 3.2x by fiscal year-end 2026, supported by strong cash flows and proceeds from asset sales.
Dividend Growth: Amcor has increased its quarterly dividend to $0.13 per share, reflecting its commitment to growing shareholder returns.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Quarterly Dividend Increase: The Board has approved an increase in Amcor's quarterly dividend to $0.13 per share.
Dividend Aristocrat Commitment: Amcor remains committed to maintaining its status as a dividend aristocrat, ensuring annual dividend growth.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What is driving the recent decline in the Flexibles business, particularly in Europe?
A:The decline in the Flexibles business, particularly in Europe, is driven by weakness in the unconverted film category, which is experiencing general market softness. This film is sold into different end markets without further processing, and those segments have been particularly weak.
Q:Can you provide an update on the North American beverage business and any progress on divestments?
A:The North American beverage business has seen operational improvements, with issues from the last quarter now under control. Although volumes softened sequentially, profitability increased. The company is exploring strategic alternatives for this noncore business, including joint ventures and partnerships, but no definitive timing has been provided.
Q:How did the high-growth categories perform compared to the overall business?
A:The high-growth categories performed better than the overall business. Health care was in line with the prior year, Beauty and Wellness was down low single digits, pet care showed strong growth, dairy saw low single-digit growth, while meat and Foodservice were weaker. Overall, the focus categories outperformed the rest of the business.
Q:What contributed to the comparable EBIT growth of 4% despite a 2.8% volume decline?
A:The EBIT growth was driven by strong cost and productivity management, including flexing the cost base, managing shift patterns, and reducing discretionary spending. Synergies also contributed significantly, with $38 million delivered in the quarter, including G&A and procurement savings.
Q:Can you elaborate on the synergies achieved from the combination of Lat Am and specialty containers with legacy Berry?
A:The combination of Lat Am and specialty containers with legacy Berry has led to synergies, including a systems solution sell involving an Amcor Rigid container and a Berry closure. The integration has also provided a contingency solution for customers and is expected to drive efficiency and effectiveness in addressing the Lat Am region.
Q:Were raw material cost savings concentrated in a specific region?
A:Raw material cost savings were general across the board and not concentrated in a specific region. Synergies in the quarter included $33 million in EBIT savings, with 2/3 from G&A and 1/3 from procurement.
Q:Does the FY '26 EPS range account for continued volume declines?
A:Yes, the FY '26 EPS range accounts for scenarios where volumes continue to decline at the 2.5% year-over-year trend observed in the first quarter. The company plans to manage costs, adjust capacities, and focus on synergy delivery to mitigate volume challenges.
Q:What is the status of divestitures and their financial impact?
A:Two divestments were announced: a small plant in Europe with sales under $20 million and a joint venture that was equity accounted. The proceeds will be used to pay down debt. The company continues to focus on other divestitures, including the North American beverage business.
Q:Are volume reductions in the North American beverage sector due to market share loss or other factors?
A:Volume reductions in the North American beverage sector are not primarily due to market share loss. However, there is some shift in multipack sales to aluminum bottles in big box stores, driven by consumer preference for value.
Q:What is the company's exposure to private-label products and current volume trends in that category?
A:The company has good exposure to private-label products in North America and Europe but is somewhat underrepresented compared to the market. Private label is a focus area for driving additional growth, as consumers seek value.
Q:What is the outlook for the health care business?
A:The health care business is considered a strong part of the portfolio. It is performing well in North America, particularly in the medical segment, while the European pharma segment is weaker. Continued improvement is expected into calendar 2026 and the back half of fiscal 2026.
Q:Review of Unclear Management Responses
A:Management avoided providing a definitive timeline for the divestment of the North American beverage business, stating that they are exploring a broad range of options but could not be more specific on timing. Additionally, they did not provide detailed financial metrics for the remaining $900 million in noncore assets or the exact impact of divestitures on leverage.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Amcor CFO
America Beverage
Beauty Wellness
Beverage volume
EBIT benefit
Global
Nutrition
Packaging Solutions
Solutions segment
acquisition basis
action
addition cost
asset sale
basis acquisition
basis net
basis point
basis sale
benefit cost
care demand
core
cost productivity
customer consumer
divestments basis
dividend
flow cash
improvement environment
increase
integration
legacy Amcor
line care
margin basis
objective
opportunity improvement
outlook
productivity delivery
quality
share midpoint
start
synergy
track
AMCR Transcript
Amcor plc (AMCR) Q3 2026 Earnings Call Transcript
Unknown5-6
The earnings call summary presents a mixed outlook. Positive aspects include reaffirmed EPS and cash flow guidance, significant synergy achievements, and increased segment sales due to acquisitions. However, concerns arise from declining volumes, inflation volatility, and management's unclear responses on key issues like inflation and volume trends. The Q&A session reveals uncertainties in cash flow and market share gains. Overall, the positive and negative factors balance out, resulting in a neutral sentiment.
Amcor plc (AMCR) Q2 2026 Earnings Call Transcript
Positive2-3
The earnings call highlights strong financial performance, with significant EBIT growth and increased dividends. The strategic focus on synergy realization and core portfolio optimization is promising, despite a slight volume decline. The Q&A reveals a consistent market outlook and potential EBIT improvements, with management addressing concerns effectively. The announcement of increased dividends and strong cash flow further supports a positive sentiment, suggesting a likely stock price increase of 2% to 8% over the next two weeks.
Amcor plc (AMCR) Q1 2026 Earnings Call Transcript
Unknown11-6
The earnings call presents mixed signals: positive EBIT growth, margin improvements, and synergies suggest strong financial health. However, challenges like volume declines, particularly in Europe, and lack of clarity on divestment timelines pose concerns. The Q&A reveals management's cautious approach and uncertainties in certain sectors. Despite strong EPS growth projections, flat volume expectations and market softness in key areas temper optimism. Without a market cap, the impact on stock price is uncertain, leading to a neutral prediction.
Amcor plc (AMCR) Q4 2025 Earnings Call Transcript
Positive8-14
The earnings call highlights strong financial performance, with significant revenue growth driven by the Berry acquisition and favorable synergies. Despite challenges in the North American beverage business, the company maintains a positive outlook with clear strategies for improvement. The focus on deleveraging and potential future share buybacks is a positive signal. The Q&A section did not reveal any major negative trends or risks, and the synergy targets are on track. Overall, the positive elements outweigh the concerns, suggesting a positive stock price movement in the near term.
AMCR Slides
AMCR Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
